findmyKOL

Marlene Moster, MD

Enriched profile

Board-certified glaucoma specialist; Professor of Clinical Ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University (Emerita/attending status referenced across sources); currently practicing at South Florida Eye Health · South Florida Eye Health

ORCIDNone on fileNPI↗
✓ Full profile
Region🇺🇸 Sunrise, FL · Southeast · United StatesSpecialtyOphthalmologyFocusGlaucoma
Active KOLfindmyKOL type: EliteLatest publication2023Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Marlene Moster is Board-certified glaucoma specialist; Professor of Clinical Ophthalmology, Sidney Kimmel Medical College, Thomas Jefferson University (Emerita/attending status referenced across sources); currently practicing at South Florida Eye Health at South Florida Eye Health. ClinicalTrials.gov lists 7 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 18 Oct 2026

Marlene Moster, MD, is Board-certified glaucoma specialist at South Florida Eye Health (Aventura, FL). The public record shows 257 publications with 5,062 citations (h-index 35), centered on Glaucoma. It also documents an investigator role on 7 registered clinical trials, industry payments reported by 25 companies.

  • Top research focus: Glaucoma
  • 7 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 25 companies

Generated from the cited public record · current as of 18 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Glaucoma7 trialsComa7 trialsWounds and Injuries1 trialExfoliation Syndrome1 trialGlaucoma, Neovascular1 trial

Research focus

OpenAlex concept fingerprint
Glaucoma

Drugs & molecules

across trials, industry payments and publications
Vyzultageneric · Latanoprostene bunodClinical trials—Industry payments154Publications—Durystageneric · BimatoprostClinical trials—Industry payments76Publications—Rocklatangeneric · Latanoprost / netarsudilClinical trials—Industry payments51Publications—Rhopressageneric · NetarsudilClinical trials—Industry payments46Publications—Simbrinzageneric · Brimonidine / brinzolamideClinical trials—Industry payments9Publications—Xiidrageneric · LifitegrastClinical trials—Industry payments9Publications—Combigangeneric · Brimonidine / timololClinical trials—Industry payments8Publications—Vuitygeneric · PilocarpineClinical trials—Industry payments7Publications—BrimonidineClinical trials—Industry payments6Publications—Miebogeneric · PerfluorohexyloctaneClinical trials—Industry payments6Publications—Inveltysgeneric · Loteprednol etabonateClinical trials—Industry payments5Publications—Iyuzehgeneric · LatanoprostClinical trials—Industry payments5Publications—

Works with

trial sponsors and companies reporting payments
Bausch & Lomb Americas Inc.Clinical trials—Industry payments152Alcon Vision LLCClinical trials—Industry payments53Abbvie Inc.Clinical trials—Industry payments49Allergan, Inc.Clinical trials—Industry payments43Aerie Pharmaceuticals, Inc.Clinical trials—Industry payments18W. L. Gore & Associates, Inc.Clinical trials—Industry payments14Bausch & Lomb, a division of Bausch Health US, LLCClinical trials—Industry payments10Sight Sciences, Inc.Clinical trials—Industry payments8Glaukos CorporationClinical trials—Industry payments7New World Medical,Inc.Clinical trials—Industry payments7Thea Pharma Inc.Clinical trials—Industry payments7Wills EyeClinical trials7Industry payments—Novartis Pharmaceuticals CorporationClinical trials—Industry payments5Regeneron Pharmaceuticals, Inc.Clinical trials—Industry payments2Sun Pharmaceutical Industries Inc.Clinical trials—Industry payments2Amgen Inc.Clinical trials—Industry payments1Argenx Us, Inc.Clinical trials—Industry payments1Genzyme CorporationClinical trials—Industry payments1Harrow Eye, LLCClinical trials—Industry payments1Horizon Therapeutics plcClinical trials—Industry payments1Kala Pharmaceuticals, Inc.Clinical trials—Industry payments1Mobius Therapeutics, LLCClinical trials—Industry payments1Omeros CorporationClinical trials—Industry payments1Oyster Point Pharma, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
35h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
7clinical trials

Investigator role on registered studies.

View trials ↓
25companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 18 Oct 2026

Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:

All 7 trial records: search, sort and filter.Explore →

Industry payments

Updated 18 Oct 2026

25 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

All 47 payment records: search, sort and filter.Explore →
View the CMS Open Payments record ↗

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    80%
    Prostaglandin Analog29%
    Latanoprost71%Lumigan21%Travoprost8%
    Part D≥120 patients
    Carbonic Anhydrase Inhibitor26.4%
    Dorzolamide-Timolol73%Dorzolamide Hcl16%Simbrinza9%Acetazolamide3%
    Part D<11 patients

    + 4 more classes in this area

  • Cardiovascular

    20%
    Beta blocker20%
    Timolol Maleate100%
    Part D≥107 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

All 0 publications: search, sort and filter.Explore →

Online presence

Updated 18 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/marlene-moster-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/profile/Marlene-Moster

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Instagram

    instagram.com/wills_eye/p/CsGzYtssXSX

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →instagram.com ↗
  • LinkedIn

    linkedin.com/posts/wills-eye-hospital_congratulations-to-dr-marlene-moster-she-activity-7062471691192430593-J_ml

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • YouTube

    youtube.com/channel/UCXwrArP8y54G_rO05biYLHQ/videos

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
  • Wioonline.org

    Speaker profile, Women in Ophthalmology (WIO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →wioonline.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 18 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    SUNY Upstate Medical University (Syracuse)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →health.usnews.com ↗
  • Internship

    Internal Medicine, Montefiore Hospital, Pittsburgh, PA

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗
  • Residency

    Ophthalmology, University of Pittsburgh (Eye & Ear Hospital)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗
  • Fellowship

    Glaucoma, Wills Eye Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗
  • Board Certified

    American Board of Ophthalmology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →npiprofile.com ↗

Editorial & leadership roles

journal and society appointments
  • Editorial Board Member

    Journal of Current Glaucoma Practice (JOCGP)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →jocgp.com ↗
  • Former Board Member

    American Glaucoma Society

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →southfloridaeyehealth.com ↗
  • Member: American Academy of Ophthalmology

    American College of Surgeons, American Glaucoma Society, American Medical Women's Association, Association for Research in Vision & Ophthalmology …

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mainlinehealth.org ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.